In addition to cell migration, tumour growth and angiogenesis in CRC inhibition in vivo and in vitro, miR-143-5p contributes to an increase in chemosensitivity of CRC cells to oxaliplatin via targeting IGF1R [157]. Here, IGF1R is linked to colorectal carcinoma.